Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Metoprolol 50mg tablets
0204000K0AAABAB
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | 53,600 |
|
Metoprolol 100mg tablets
0204000K0AAACAC
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | 15,328 |
|
Metoprolol 25mg tablets
0204000K0AABNBN
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | 9,578 |
|
Metoprolol 12.5mg/5ml oral suspension
0204000K0AABLBL
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | 45 |
|
Metoprolol 12.5mg/5ml oral solution
0204000K0AABKBK
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | 29 |
|
Metoprolol 200mg modified-release tablets
0204000K0AAADAD
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | 22 |
|
Metoprolol 50mg/5ml oral solution
0204000K0AABMBM
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | 18 |
|
Metoprolol 50mg/5ml oral suspension
0204000K0AAATAT
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | 8 |
|
Metoprolol 5mg/5ml solution for injection ampoules
0204000K0AAAAAA
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | 4 |
|
Metoprolol 12.5mg capsules
0204000K0AAAFAF
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | 1 |
|
Metoprolol 100mg/5ml oral solution
0204000K0AAAQAQ
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 10mg/5ml oral liquid
0204000K0AAAMAM
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 125mg/5ml oral solution
0204000K0AAAWAW
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 15mg/5ml oral solution
0204000K0AAAYAY
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 16mg/5ml oral solution
0204000K0AABFBF
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 17mg/5ml oral solution
0204000K0AABJBJ
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 2.5mg/5ml oral solution
0204000K0AAAPAP
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 20mg/5ml oral liquid
0204000K0AAAZAZ
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 25mg/5ml oral liquid
0204000K0AAASAS
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 3.33mg/5ml oral solution
0204000K0AABABA
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 30mg/5ml oral solution
0204000K0AABHBH
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 31.25mg/5ml oral solution
0204000K0AABIBI
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 40mg/5ml oral solution
0204000K0AAARAR
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 5mg/5ml oral liquid
0204000K0AAANAN
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
|
Metoprolol 6.25mg/5ml oral solution
0204000K0AABBBB
|
Metoprolol tartrate | Metoprolol tartrate | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.